Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Microcide and Althexis merge in all-stock transaction

Executive Summary

Microcide Pharmaceuticals will issue 55.5mm common shares to acquire Althexis Co. in a $23.35mm stock swap. The transaction will be tax-free and accounted for using the purchase method. Microcide will change its name to Essential Therapeutics Inc. with Althexis functioning as a subsidiary.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Stock

Related Companies